The emerging use of aromatase inhibitors for endometriosis treatment
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Endometriosis is defined as the growth of endometrial tissue outside of the uterine cavity. The disease occurs primarily in women of reproductive age but recurrent endometriosis is also detected in post-menopausal women. Regardless of age, endometriosis is associated with pain and reduces the quality of life for millions of women world-wide. Conventional therapies focus on reducing systemic levels of estrogen which results in cessation of endometriotic implant growth and pain symptoms associated with the disease. However, these treatments are not effective in all women and are not without side effects. Based upon the discovery that endometriotic tissue over-expresses aromatase, an enzyme critical for estrogen production, emphasis has been placed upon the use of aromatase inhibitors for the treatment of endometriosis and its associated symptoms. This article will review the rationale behind the use of aromatase inhibitors in treating endometriosis and summarize those studies which have evaluated the use of aromatase inhibitors in the treatment of endometriosis and its associated symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 1×
“The first report describing expression of aromatase in peritoneal endometriotic implants was published in 1996 by Noble and colleagues [1].”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Soysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 2×
“N = 40 goserelin + anastrozole) Decreased symptom recurrence rate Increased pain-free interval [21] Soysal et al.”
BackgroundZeitoun, K., Takayama, K., Michael, M. D., & Bulun, S. E. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0229 · Cited by 216
Šmuc, T., Pucelj, M. R., Šinkovec, J., Husen, B., Thole, H., & Rižner, T. L. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601152219 · Cited by 124
Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis
Velasco, I. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal041 · Cited by 108 · cited 2×
“Since this initial report, numerous independent investigators have described the expression and cellular localization of aromatase transcript and protein in endometriotic tissue [ 2-8 ] as well as eutopic endometrium from women with the disease [2,3,5,8-13].”
BackgroundGenetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue
Fang, Z., Yang, S., Gurates, B., Tamura, M., Simpson, E., Evans, D., & Bulun, S. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8683 · Cited by 91 · cited 1×
“Mice with experimentally-induced endometriosis in which the expression of aromatase has been genetically disrupted exhibit significantly smaller endometriotic implants [38] validating the use of such animal models.”
BackgroundIzawa, M., Harada, T., Taniguchi, F., Ohama, Y., Takenaka, Y., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.078 · Cited by 83 · cited 2×
“Using isolated stromal cells from endometriotic chocolate cysts and endometrial biopsies, Izawa and colleagues [15] demonstrated that endometriotic stromal cells secrete estrogen and that this secretion could be increased by addition of testosterone to the media.”
BackgroundResultLetrozole and norethisterone acetate in colorectal endometriosis
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., Seracchioli, R., & Remorgida, V. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.023 · Cited by 80
Cited by
The evolutionary biology of endometriosis
Dinsdale, N., Nepomnaschy, P., & Crespi, B. (2021) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoab008 · Cited by 53
A peek into the drug development scenario of endometriosis – A systematic review
Goenka, L., George, M., & Sen, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.092 · Cited by 37
Is a bowel resection necessary for deep endometriosis with rectovaginal or colorectal involvement?
Acien, P., Núñez, Quereda, Velasco, Valiente, & Vidal (2013) · International Journal of Women's Health · doi:10.2147/ijwh.s46519 · Cited by 36
Metadata
- Authors
- Nothnick, W. B.
- Venue
- Reproductive Biology and Endocrinology
- Published
- 2011
- Volume
- 9
- Issue
- 1
- Pages
- 87
- ISSN
- 1477-7827 (ISSN-L)
- OpenAlex
- W2167064297
- Cited by
- 55
- References
- 12
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The emerging use of aromatase inhibitors for endometriosis treatment. https://app.cochat.ai/papers/10.1186/1477-7827-9-87
- The paper
- Nothnick, W. B. (2011). The emerging use of aromatase inhibitors for endometriosis treatment. Reproductive Biology and Endocrinology. https://doi.org/10.1186/1477-7827-9-87
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.